Probenecid
Back to searchMolecule Structure
Scientific Name
Probenecid
Description of the Drug
Probenecid is a medication used to treat gouty arthritis, tophaceous gout, and hyperuricemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01032
http://www.drugbank.ca/drugs/DB01032
Brand Name(s)
Benemid, Benuryl, Probalan, Probampicin, Probecid, Probenecid
Company Owner(s)
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Lederle Laboratories Div American Cyanamid Co, Impax Laboratories Inc, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Apothecon Inc Div Bristol Myers Squibb, Sandoz Inc, Watson Laboratories Inc, Novast Laboratories Ltd, Merck And Co Inc, Ani Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Solute carrier family 22 member 6 | SINGLE PROTEIN | INHIBITOR | CHEMBL1641347 |
Solute carrier family 22 member 11 | SINGLE PROTEIN | INHIBITOR | CHEMBL2073677 |
Solute carrier family 22 member 8 | SINGLE PROTEIN | INHIBITOR | CHEMBL1641348 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3663 | |||
PharmGKB | PA451106 | |||
Human Metabolome Database | HMDB0015166 | |||
DrugBank | DB01032 | |||
PubChem: Thomson Pharma | 14873183 | |||
PubChem | 4911 | |||
Mcule | MCULE-8664946016 | |||
LINCS | LSM-4140 | |||
Nikkaji | J1.382J | |||
BindingDB | 50206509 | |||
EPA CompTox Dashboard | DTXSID9021188 | |||
DrugCentral | 2268 | |||
Brenda | 154394 | 44642 | 153409 | 3131 |
ChemicalBook | CB9134579 | |||
Guide to Pharmacology | 4357 | |||
rxnorm | PROBENECID | |||
KEGG Ligand | C07372 | |||
ChEBI | 8426 | |||
ZINC | ZINC000000001982 |